Skip to main content
. 2016 Aug 15;11(8):e0160460. doi: 10.1371/journal.pone.0160460

Table 3. Characteristics of eligible patients 10 years after start of ART, together with unadjusted and adjusted hazard ratios (HR).

 Characteristics Number (%) of patients Number (%) of deaths Unadjusted HR Adjusted HR
(95% CI) (95% CI)*
Total 13,011 (100%) 656 (100%)
Risk group
IDU (vs non-IDU) 1,636 (13%) 121 (7%) 2.54 (2.03, 3.18) 2.58 (2.04, 3.26)
Sex
Female (vs male) 2,701 (21%) 81 (3%) 0.76 (0.60, 0.96) 0.95 (0.74, 1.21)
AIDS diagnosis
No AIDS 8,661 (67%) 302 (3%) 1 1
AIDS before ART start 2,714 (21%) 175 (6%) 1.73 (1.43, 2.09) 1.48 (1.23, 1.80)
AIDS between ART start and 10 years afterwards 1,636 (13%) 179 (11%) 2.14 (1.75, 2.62) 1.68 (1.37, 2.06)
Age (years)
Median (IQR) 46 (41, 53)
16–39 2,330 (18%) 53 (2%) 1 1
40–49 6,029 (46%) 225 (4%) 1.50 (1.11, 2.03) 1.40 (1.04, 1.90)
50–59 3,129 (24%) 200 (6%) 2.15 (1.58, 2.92) 2.14 (1.56, 2.92)
60–69 1,181 (9%) 123 (10%) 3.39 (2.44, 4.71) 4.29 (3.06, 6.02)
≥70 342 (3%)  55 (16%) 6.18 (4.22, 9.04) 8.59 (5.82, 12.7)
CD4 count (cells/μL)
Median (IQR) 550 (372, 760)
≥750 3,396 (26%) 92 (3%) 1 1
500–749 4,093 (31%) 126 (3%) 1.12 (0.85, 1.46) 1.01 (0.78, 1.33)
350–499 2,644 (20%) 128 (5%) 1.72 (1.32, 2.25) 1.41 (1.07, 1.84)
200–349 1,850 (14%) 131 (7%) 2.37 (1.81, 3.10) 1.80 (1.37, 2.37)
100–199 628 (5%) 81 (13%) 4.28 (3.16, 5.78) 3.07 (2.24, 4.19)
0–99 400 (3%) 98 (25%) 9.25 (6.90, 12.4) 6.17 (4.46, 8.53)
Viral load (HIV-1 RNA copies/mL)
Median (% with RNA≤50) 50 (75%)
0–50 9,814 (75%) 370 (4%) 1 1
51–1000 1,690 (13%) 119 (7%) 1.25 (1.00, 1.56) 1.09 (0.87, 1.36)
>1000 1,507 (12%) 167 (11%) 2.41 (1.99, 2.91) 1.74 (1.40, 2.15)

IDU: injection drug use; IQR: inter-quartile range; CI: confidence interval

*Models adjusted for all variables in table, stratified by cohort.